Yu‐De Chu

678 total citations
48 papers, 482 citations indexed

About

Yu‐De Chu is a scholar working on Molecular Biology, Epidemiology and Hepatology. According to data from OpenAlex, Yu‐De Chu has authored 48 papers receiving a total of 482 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Molecular Biology, 14 papers in Epidemiology and 12 papers in Hepatology. Recurrent topics in Yu‐De Chu's work include Hepatitis B Virus Studies (10 papers), Cancer, Hypoxia, and Metabolism (8 papers) and Liver Disease Diagnosis and Treatment (8 papers). Yu‐De Chu is often cited by papers focused on Hepatitis B Virus Studies (10 papers), Cancer, Hypoxia, and Metabolism (8 papers) and Liver Disease Diagnosis and Treatment (8 papers). Yu‐De Chu collaborates with scholars based in Taiwan, United States and United Kingdom. Yu‐De Chu's co-authors include Chau‐Ting Yeh, Ming‐Wei Lai, Wey‐Ran Lin, Siew‐Na Lim, Yang-Hsiang Lin, Ya‐Hui Huang, Kung‐Hao Liang, Chih‐Lang Lin, Shih‐Peng Chan and Kwang‐Huei Lin and has published in prestigious journals such as Hepatology, International Journal of Molecular Sciences and Developmental Biology.

In The Last Decade

Yu‐De Chu

44 papers receiving 477 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yu‐De Chu Taiwan 14 239 118 93 65 61 48 482
Yanghui Bi China 12 205 0.9× 87 0.7× 43 0.5× 74 1.1× 27 0.4× 25 352
Tai-Shan Cheng Taiwan 13 258 1.1× 53 0.4× 46 0.5× 65 1.0× 39 0.6× 14 383
Marcel Kap Netherlands 11 244 1.0× 63 0.5× 48 0.5× 46 0.7× 27 0.4× 17 477
Raymond J. Peroutka United States 11 487 2.0× 68 0.6× 47 0.5× 72 1.1× 23 0.4× 12 631
Su‐Jun Li China 13 386 1.6× 54 0.5× 62 0.7× 75 1.2× 21 0.3× 16 601
Rajani Rai United States 14 261 1.1× 99 0.8× 55 0.6× 129 2.0× 25 0.4× 48 737
Seung Oe Lim South Korea 9 394 1.6× 71 0.6× 133 1.4× 61 0.9× 80 1.3× 9 588
Jaione Simón-Santamaría Norway 10 168 0.7× 53 0.4× 201 2.2× 70 1.1× 206 3.4× 18 583

Countries citing papers authored by Yu‐De Chu

Since Specialization
Citations

This map shows the geographic impact of Yu‐De Chu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yu‐De Chu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yu‐De Chu more than expected).

Fields of papers citing papers by Yu‐De Chu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yu‐De Chu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yu‐De Chu. The network helps show where Yu‐De Chu may publish in the future.

Co-authorship network of co-authors of Yu‐De Chu

This figure shows the co-authorship network connecting the top 25 collaborators of Yu‐De Chu. A scholar is included among the top collaborators of Yu‐De Chu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yu‐De Chu. Yu‐De Chu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chen, Chih‐Cheng, Li‐Fang Chou, Chau‐Ting Yeh, et al.. (2025). Corylin attenuates oral squamous cell carcinoma progression through c-Myc inhibition. Journal of Dental Sciences. 20(4). 2322–2331.
2.
Graaf, Winette T.A. van der, Nam Bui, Gina Z. D’Amato, et al.. (2025). 67MO Long-term nirogacestat treatment in adult patients with desmoid tumors: Updated efficacy and safety from the phase III DeFi trial. ESMO Open. 10. 104381–104381. 1 indexed citations
3.
Chu, Yu‐De, et al.. (2025). Mitochondrial echoes in the bloodstream: decoding ccf-mtDNA for the early detection and prognosis of hepatocellular carcinoma. Cell & Bioscience. 15(1). 118–118. 1 indexed citations
4.
Lin, Yang-Hsiang, Yu‐De Chu, Kwang‐Huei Lin, et al.. (2025). HBx mutant-regulated RPL13AP25 mediates suboptimal virological response to entecavir and HCC progression. Cancer Cell International. 25(1). 223–223. 1 indexed citations
6.
Huang, Ziyu, Yu‐De Chu, Cheng–En Ho, Yu-An Shen, & Chih‐Ming Chen. (2024). Interfacial reaction and thermomigration of copper/indium joints. Journal of Materials Research and Technology. 34. 2051–2059. 4 indexed citations
7.
Chu, Yu‐De, Li-Chun Cheng, Siew‐Na Lim, et al.. (2023). Aldolase B-driven lactagenesis and CEACAM6 activation promote cell renewal and chemoresistance in colorectal cancer through the Warburg effect. Cell Death and Disease. 14(10). 660–660. 34 indexed citations
8.
Chu, Yu‐De, et al.. (2023). Bioenergetic alteration in gastrointestinal cancers: The good, the bad and the ugly. World Journal of Gastroenterology. 29(29). 4499–4527. 10 indexed citations
9.
Chu, Yu‐De, Ming‐Wei Lai, & Chau‐Ting Yeh. (2023). Unlocking the Potential of Arginine Deprivation Therapy: Recent Breakthroughs and Promising Future for Cancer Treatment. International Journal of Molecular Sciences. 24(13). 10668–10668. 17 indexed citations
10.
Chu, Yu‐De, Tan‐Chi Fan, Ming‐Wei Lai, & Chau‐Ting Yeh. (2022). GALNT14-mediated O-glycosylation on PHB2 serine-161 enhances cell growth, migration and drug resistance by activating IGF1R cascade in hepatoma cells. Cell Death and Disease. 13(11). 956–956. 27 indexed citations
11.
Fan, Wen‐Lang, Yu‐De Chu, Kung‐Hao Liang, et al.. (2020). Whole-Exome Sequencing Identified Novel CLMP Mutations in a Family With Congenital Short Bowel Syndrome Presenting Differently in Two Probands. Frontiers in Genetics. 11. 574943–574943. 7 indexed citations
12.
Chu, Yu‐De, Li‐Mei Pai, Ya‐Hui Huang, et al.. (2019). The methionine salvage pathway-involving ADI1 inhibits hepatoma growth by epigenetically altering genes expression via elevating S-adenosylmethionine. Cell Death and Disease. 10(3). 240–240. 23 indexed citations
13.
Chu, Yu‐De, Kwang‐Huei Lin, Ya‐Hui Huang, et al.. (2018). A novel thyroid function index associated with opposite therapeutic outcomes in advanced hepatocellular carcinoma patients receiving chemotherapy or sorafenib. Asia-Pacific Journal of Clinical Oncology. 14(5). e341–e351. 8 indexed citations
15.
Lin, Chih‐Lang, Yu‐De Chu, & Chau‐Ting Yeh. (2018). Emergence of Oncogenic‐Enhancing Hepatitis B Virus X Gene Mutants in Patients Receiving Suboptimal Entecavir Treatment. Hepatology. 69(5). 2292–2296. 13 indexed citations
16.
Lin, Wey‐Ran, Chao‐Wei Hsu, Yi‐Cheng Chen, et al.. (2017). Combinations of single nucleotide polymorphisms WWOX‐rs13338697, GALNT14‐rs9679162 and rs6025211 effectively stratify outcomes of chemotherapy in advanced hepatocellular carcinoma. Asia-Pacific Journal of Clinical Oncology. 14(2). e54–e63. 10 indexed citations
17.
Chu, Yu‐De, et al.. (2015). A novel function for the DEAD-box RNA helicase DDX-23 in primary microRNA processing in Caenorhabditis elegans. Developmental Biology. 409(2). 459–472. 17 indexed citations
18.
Lee, Li‐Wei, Yu‐De Chu, Yi‐Tzang Tsai, et al.. (2015). A Genetic Cascade of let-7-ncl-1-fib-1 Modulates Nucleolar Size and rRNA Pool in Caenorhabditis elegans. PLoS Genetics. 11(10). e1005580–e1005580. 35 indexed citations
19.
Chu, Yu‐De, et al.. (2014). RACK-1 regulateslet-7microRNA expression and terminal cell differentiation inCaenorhabditis elegans. Cell Cycle. 13(12). 1995–2009. 19 indexed citations
20.
Yan, Shushan & Yu‐De Chu. (2007). Hookworm infestation of the small intestine: an unusual cause of obscure gastrointestinal bleeding. Endoscopy. 39(S 1). E162–E163. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026